AcquisitionsJul 27, 2026, 08:16 AM
Novanta Completes Riverpoint Medical Acquisition for $1.2B
AI Summary
Novanta Inc. completed its acquisition of Riverpoint Medical on July 23, 2026, for approximately $1.2 billion in cash, with an additional $250.0 million milestone payment due by January 8, 2027. The acquisition was funded by borrowing $616.0 million and using cash on hand, increasing Novanta's consolidated debt to $854.7 million. This strategic move is expected to double Novanta's recurring medical consumables revenue to $300 million, increase medical end-market exposure to 60% of total revenue, and contribute $0.18 to $0.25 to adjusted EPS in 2027.
Key Highlights
- Completed acquisition of Riverpoint Medical on July 23, 2026.
- Paid approximately $1.2 billion in cash for the acquisition.
- A milestone payment of $250.0 million is due by January 8, 2027.
- Funded the acquisition by borrowing $616.0 million and using cash on hand.
- Consolidated debt totals $854.7 million after the borrowing.
- Expected to contribute $0.18 to $0.25 adjusted EPS in 2027.
- Expected to double recurring medical consumables revenue to $300 million.
- Medical end-market exposure expected to increase to 60% of total revenue.
Price Impact
More from NOVT